TY - JOUR
KW - Adult
KW - Analgesics, Opioid/adverse effects/therapeutic use
KW - Combined Modality Therapy
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Life Style
KW - Male
KW - Middle Aged
KW - Narcotic-Related Disorders/epidemiology/rehabilitation
KW - Pulmonary Disease, Chronic Obstructive/chemically induced/diagnosis/epidemiology
KW - Risk Factors
KW - Smoking Cessation
KW - Spirometry
KW - Switzerland
KW - case finding
KW - chronic obstructive pulmonary disease
KW - opioid agonist treatment
KW - opioid dependence
KW - opioid substitution treatment
KW - people with opioid use disorder
KW - Screening
AU - T. Grischott
AU - L. Falcato
AU - O. Senn
AU - M. A. Puhan
AU - P. Bruggmann
A1 - 
AD - Institute of Primary Care (IHAMZ), University and University Hospital of Zurich, Zurich, Switzerland.; Arud Centre for Addiction Medicine, Zurich, Switzerland.; Institute of Primary Care (IHAMZ), University and University Hospital of Zurich, Zurich, Switzerland.; Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.; Institute of Primary Care (IHAMZ), University and University Hospital of Zurich, Zurich, Switzerland.; Arud Centre for Addiction Medicine, Zurich, Switzerland.
BT - Addiction (Abingdon, England)
C5 - Measures; Opioids & Substance Use
CP - 5
CY - England
DO - 10.1111/add.14559
IS - 5
JF - Addiction (Abingdon, England)
LA - eng
M1 - Journal Article
PB - Society for the Study of Addiction
PP - England
PY - 2019
SN - 1360-0443; 0965-2140
SP - 868
EP - 876
EP - 
T1 - Chronic obstructive pulmonary disease (COPD) among opioid-dependent patients in agonist treatment. A diagnostic study
T2 - Addiction (Abingdon, England)
TI - Chronic obstructive pulmonary disease (COPD) among opioid-dependent patients in agonist treatment. A diagnostic study
U1 - Measures; Opioids & Substance Use
U2 - 30675957
U3 - 10.1111/add.14559
VL - 114
VO - 1360-0443; 0965-2140
Y1 - 2019
Y2 - May
ER -